Clinical trial
Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)
NCT00909883 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Foot Dystonia Treatment by Botulinum Toxin Injections in Parkinson Disease : Efficiency of Injections Made in Extrinsic Muscle (Flexor Digitorum Longus Muscle) Compared to Intrinsic Muscle (Flexor Digitorum Brevis or Quadratus Plantae Muscles)
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 30, 2009
- Completion date
- September 30, 2012
- Enrollment
- 45 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
foot dystonia, parkinson's disease